Louis Vuitton owner LVMH has agreed to buy Tiffany for $16.2 billion in its biggest acquisition yet as the French luxury goods maker bets it can restore the iconic U.S. jeweler’s luster.
Land Securities Group plc (LON:LAND), which is in the reits business, and is based in United Kingdom, led the LSE… …read more […]
China’s new energy vehicle (NEV) market is likely to see a sales rebound next year as automakers roll out more new products to lure buyers, but more supportive government policies are needed, auto executives said.
GUANGZHOU, China/Shanghai (Reuters) – China’s new energy vehicle (NEV) market is likely to see a sales rebound next year as automakers roll out more new products to lure buyers, but more supportive government policies are needed, auto executives said. China has been a keen supporter of NEVs and has implemented production quota requirements for automakers. In October, NEV sales fell 45.6% from year-ago levels. …read more […]
Oil prices rose on Monday as positive comments from the United States and China rekindled hopes in global markets that the world’s two largest economies could soon sign an interim deal to end their bitter trade war.
Indian digital payments company Paytm said on Monday it has raised fresh funds from a group of investors including existing backers SoftBank’s Vision Fund and China’s Ant Financial Services in a deal valuing the firm at $16 billion.
Swiss drugmaker Novartis is betting on heart drug prospect inclisiran in a $9.7 billion takeover of The Medicines Co as it challenges cardiovascular medicines from Amgen Inc , Sanofi and Regeneron Pharmaceuticals .
Roche expects its risdiplam medicine for spinal muscular atrophy (SMA) to get U.S. approval by May, the Swiss drugmaker said on Monday, as it takes on Novartis and Biogen in the lucrative rare disease area. The U.S. Food and Drug Administration granted priority review for risdiplam, an oral medicine for those with the potentially deadly muscle-wasting disorder. Roche, whose drug is seen as a rival for Biogen’s Spinraza and Novartis’s Zolgensma gene therapy, said the FDA is due to decide by May 24. …read more […]
European shares rose for the second straight session on Monday following reports that Washington and Beijing were nearing a trade agreement, while LVMH gained after signing a deal to buy U.S. jewellery chain Tiffany. A Chinese state-backed tabloid said on Monday China and the United States were “very close” to an initial trade agreement, adding to optimism from Friday, when the presidents of both the countries reiterated their desire for a deal. The pan-European STOXX 600 index was up 0.6% at 0802 GMT, led by trade-sensitive miners. …read more […]
Louis Vuitton owner LVMH has agreed to buy U.S. jeweler Tiffany for $16.2 billion in the luxury goods maker’s biggest acquisition to date.
(Bloomberg) — Istanbul is working on a plan to sell Eurobonds to finance projects after state lenders “shut the doors” on the city’s opposition-run local government, according to Mayor Ekrem Imamoglu.“It’s sad that the state lenders remain distant to us since we came into office,” Imamoglu told reporters on Sunday. “I don’t know what their motives are. However, I have no doubt that we will find funding from Europe.”The new mayor’s remarks highlight the difficulties he faces running the nation’s largest city after wresting control from Presidetn Recep Tayyip Erdogan’s ruling AK Party. Imamoglu was in London earlier this month …read more […]
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is… …read more […]
Today, we’ll introduce the concept of the P/E ratio for those who are learning about investing. We’ll show how you can… …read more […]
China’s foreign ministry said on Monday it hopes the United States will work with Beijing on a basis of equality and mutual respect on the ongoing bilateral trade negotiations.
LVMH has agreed a $16.2 billion deal to buy U.S. jeweler Tiffany, Louis Vuitton’s parent firm confirmed on Monday, in the luxury good maker’s biggest purchase to date.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
